Immuron (IMRN) Return on Assets (2018 - 2025)
Immuron (IMRN) posted quarterly Return on Assets of 4942767410.96% for Q3 2025, up 494276741096.0% year-on-year from N/an in Q3 2024, and up 117.08% on a QoQ basis from 2276983904.12% in Q2 2025.
Immuron (IMRN) Return on Assets (2018 - 2025) Analysis & Trends
Immuron (IMRN) has reported Return on Assets for 8 consecutive years, with 4942767410.96% the latest figure, recorded in Q3 2025.
- Quarterly Return on Assets rose 494276741096.0% year-over-year to 4942767410.96% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 4942767410.96% (up 494276741096.0% YoY) and the FY2025 annual result came in at 0.01%, down 1.0% from the prior year.
- Return on Assets grew to 4942767410.96% in Q3 2025 per IMRN's latest filing, from 2276983904.12% in the prior quarter.
- Over the last five years, Return on Assets for IMRN reached as high as 4942767410.96% in Q3 2025 and fell as low as 0.0% in Q4 2023.
- A 5-year average of 1028900082.2% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2022 — Return on Assets changed 0 bps — and 2025, when it jumped 2000000000 bps.
- Year by year, Return on Assets stood at 0.0% in 2021, then tumbled by 207 bps to 0.0% in 2022, then slumped by 1835 bps to 0.0% in 2023, then surged by 2000000000 bps to 4098149589.09% in 2024, then gained by 21 bps to 4942767410.96% in 2025.
- According to Business Quant data, Return on Assets over the past three periods registered 4942767410.96%, 2276983904.12%, and 4098149589.09% for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.01% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -0.80% |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 0.00% |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | 4,942,767,410.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 4,942,767,410.96% |
| Jun 30, 2025 | 2,276,983,904.12% |
| Dec 31, 2024 | 4,098,149,589.09% |
| Sep 9, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Aug 31, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Jun 30, 2020 | -0.01% |
| Dec 31, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Jun 30, 2018 | 0.00% |